Simplex Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Simplex Trading’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-624	Closed	-$7K	–	8675
2024 Q3	$7K	Buy	+624	New	+$10.5K	﹤0.01%	7409
2024 Q1	–	Sell	-808	Closed	-$15K	–	8993
2023 Q4	$15K	Sell	808 -1,032	-56%	-$19.6K	﹤0.01%	7126
2023 Q3	$31K	Sell	1,840 -5,776	-76%	-$137K	﹤0.01%	6220
2023 Q2	$228K	Buy	7,616 +840	+12%	+$27.6K	﹤0.01%	4154
2023 Q1	$198K	Sell	6,776 -5,200	-43%	-$150K	﹤0.01%	4330
2022 Q4	$236K	Sell	11,976 -608	-5%	-$16.6K	﹤0.01%	4022
2022 Q3	$380K	Buy	12,584 +5,316	+73%	+$146K	﹤0.01%	3793
2022 Q2	$167K	Sell	7,268 -148	-2%	-$4.06K	﹤0.01%	4847
2022 Q1	$331K	Buy	7,416 +5,576	+303%	+$220K	﹤0.01%	4395
2021 Q4	$70K	Buy	1,840 +1,804	+5,011%	+$81.8K	﹤0.01%	6778
2021 Q3	$2K	Buy	+36	New	+$1.81K	﹤0.01%	9510

Other funds holding CTXR

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

AAG

Asset Advisory Group Kinnelon, New Jersey $229M AUM

Simplex Trading's CTXR Position: Q2 2026 in Review

Simplex Trading opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 1,256 shares worth $759. The stake represents ﹤0.01% of the portfolio and ranks #8883 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CTXR as recently as Q3 2025.

Simplex Trading first reported a position in CTXR in Q3 2021 and has held it in 13 quarters since. The position peaked at $62K in Q3 2021. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

Simplex Trading held 1,256 shares of Citius Pharmaceuticals worth $759 as of Q2 2026.
Citius Pharmaceuticals was a new Simplex Trading position in Q2 2026.
Citius Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8883 holding.
Simplex Trading first reported a position in Citius Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
Simplex Trading's Citius Pharmaceuticals position peaked at $62K in Q3 2021.
43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.